Melissa K. Accordino, MD, MS, discusses the utility of liquid biopsies in breast cancer.
Katherine D. Crew, MD, MS, discusses recent advances made in HER2-positive breast cancer treatment.
Melissa K. Accordino, MD, MS, discusses the findings of the PEARL trial in hormone receptor-positive, HER2-negative metastatic breast cancer.
Jason D. Wright, MD, discusses the findings of this trial and how practice can shift to decrease the gap between African-American and white patients with endometrial cancer.
Dawn L. Hershman, MD, MS, discusses the design of the phase III TAILORx trial in hormone receptor (HR)–positive, HER2-negative breast cancer.
Katherine D. Crew, MD, MS, discusses the results of the APHINITY trial in HER2-positive breast cancer.
Eileen Connolly, MD, PhD, discusses the possible benefit of postmastectomy radiation for patients with breast cancer.
Katherine Crew, MD, MS, discusses treatment for patients with favorable-risk early-stage HER2-positive breast cancer.